Illumina · 4 days ago
Senior Controls Engineer
Illumina is expanding access to genomic technology to realize health equity for billions of people around the world. The Senior Controls Engineer will design controllers for precise motion and collaborate closely with various engineering disciplines to develop and optimize these systems.
BiotechnologyGeneticsHealth CareMedical
Responsibilities
Develop controller architectures
Evaluate potential disturbances to the system
Analyze the controller architectures and systems in simulations
Analyze systems and structures to optimize designs for system stability
Develop novel controller techniques to minimize the impact of external disturbances
Test & optimize designed controllers on physical systems
Successfully transition designs from concept to production
Perform root cause analysis and lead teams to methodically solve problems
Communicate clearly with team members and leaders
Qualification
Required
Familiarity with electromechanical and thermal system modeling and control
Control theory including dynamic modeling, PID control design, feedforward, and frequency domain analysis
Experience in digital controller development and analysis
Programming in Python or C/C++ or similar
Signal processing including FFT and filter design
Vibration analysis and modeling
Experience in practical controller testing on hardware
Experience in motor selection and qualification (steppers, servos)
Proven experience successfully transferring designs to manufacturing
Experience with modeling and analysis programs (Matlab/Simulink or similar)
Experience managing multiple controllers at different complexities
Typically requires a minimum of 8 years of related experience with a Bachelor's degree; or 6 years and a Master's degree; or a PhD with 3 years experience; or equivalent experience
Preferred
Advanced controller concepts, including state space design and LQR
Experience with thermal control & sensing
Experience with control of optomechanical systems
Experience in nanometer-scale precision motion
Three phase motor control techniques, including field-oriented control (FOC)
Benefits
Access to genomics sequencing
Family planning
Health/dental/vision
Retirement benefits
Paid time off
Company
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Funding
Current Stage
Public CompanyTotal Funding
$1.28BKey Investors
Bank of America
2024-09-06Post Ipo Debt· $500M
2023-01-04Post Ipo Debt· $750M
2000-07-28IPO
Leadership Team
Recent News
businessweekly.co.uk
2026-01-11
BioWorld Financial Watch
2026-01-11
Company data provided by crunchbase